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Abstract 21 
A photochemically-induced fluorescence system combined with second-order chemometric 22 
analysis for the determination of the anticonvulsant carbamazepine (CBZ) is presented. CBZ 23 
is a widely used drug for the treatment of epilepsy and is included in the group of emerging 24 
contaminant present in the aquatic environment. CBZ is not fluorescent in solution but can be 25 
converted into a fluorescent compound through a photochemical reaction in a strong acid 26 
medium. The determination is carried out by measuring excitation-emission photoinduced 27 
fluorescence matrices of the products formed upon ultraviolet light irradiation in a laboratory-28 
constructed reactor constituted by two simple 4 W germicidal tubes. Working conditions 29 
related to both the reaction medium and the photoreactor geometry are optimized by an 30 
experimental design. The developed approach enabled the determination of CBZ at trace 31 
levels without the necessity of applying separation steps, and in the presence of uncalibrated 32 
interferences which also display photoinduced fluorescence and may be potentially present in 33 
the investigated samples. Different second-order algorithms were tested and successful 34 
resolution was achieved using multivariate curve resolution-alternating least-squares (MCR-35 
ALS). The study is employed for the discussion of the scopes and yields of each of the 36 
applied second-order chemometric tools. The quality of the proposed method is probed 37 
through the determination of the studied emerging pollutant in both environmental and 38 
drinking water samples. After a pre-concentration step on a C18 membrane using 50.0 mL of 39 
real water samples, a prediction relative error of 2 % and limits of detection and 40 
quantification of 0.2 and 0.6 ng mL
–1
 were respectively obtained. 41 
 42 
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1. Introduction 47 
Carbamazepine (CBZ), 5H-dibenzo[b,f]azepine-5-carboxamide (Fig. 1) is an 48 
anticonvulsant drug widely used for the treatment of epilepsy and psychiatric diseases [1], 49 
and is included in the group of emerging contaminants [2]. This pharmaceutical pollutant is 50 
of particular concern because of its important toxicological and pharmacological effects in 51 
mammals, humans and the aquatic environment [3–6], in addition to the harmful 52 
consequences produced by its major photoproduct, acridine [7,8].  53 
 54 
Fig. 1 Structure of carbamazepine and potential interferences. 55 
 56 
 Environmental studies have demonstrated that CBZ is one of the most frequently detected 57 
pharmaceutical in sewage-treatment plant effluents, river water and drinking water [9,10]. A 58 
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field study of occurrence and fate of CBZ and other five pharmaceuticals in surface waters of 59 
Switzerland concluded that CBZ reached concentrations of 0.4 and 0.95 ng mL
–1
 in river and 60 
wastewater treatment plant effluents, respectively [11]. An European Union (EU) monitoring 61 
study for organic compounds in rivers and streams across Europe indicated that CBZ is one 62 
of the most frequently detected compound (95%), with an average concentration of 0.25 ng 63 
mL
–1
 and maximum concentrations of about 11 ng mL
–1
 [12]. A recent study related to the 64 
occurrence of polar organic pollutants in EU ground waters included CBZ in the list of most 65 
frequently found pharmaceuticals (42.1 %), with a maximum concentration of 0.39 ng mL
–1
 66 
[13].  67 
 CBZ seems to be persistent in the environment, therefore qualifying as a suitable marker 68 
for anthropogenic influences on the aquatic environment [14]. The determination of CBZ and 69 
atrazine was employed as a target analysis for tracers of organic contamination in drinking 70 
and surface waters, resulting in a useful tool to prioritize samples which should be further 71 
screened for suspect contaminants [15]. 72 
 Very recently, during the analysis of selected pharmaceuticals in fish and surface waters 73 
directly affected by irrigation with reclaimed water, CBZ was consistently detected, with a 74 
significant bioaccumulation factor in mosquito fish [16]. 75 
Chromatographic methods are the most commonly applied ones for the determination of 76 
CBZ or its photodegradation products in different matrices [9–39], although 77 
spectrophotometric, mass spectrometric, electrochemical and capillary electrophoretic 78 
methods have also been proposed [40–47]. Since CBZ is not fluorescent in solution, 79 
fluorimetric methods for its determination have been developed in a nylon surface [48] or 80 
through the formation of fluorescent derivatives by oxidation with Ce(IV) [49,50], 81 
permanganate [51] and lead dioxide [52], or by photochemical reaction [53]. 82 
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The determination of contaminants in complex samples brings the problem of the presence 83 
of interfering agents which must be removed, extending the analysis time and the 84 
experimental work. On the other hand, these separative steps frequently involve the use of 85 
organic solvents which are harmful to health and pollute the environment. In this regard, with 86 
the purpose of contributing with the protection of the environment and decreasing the health 87 
impact, there is a particular interest in developing methods for analytes of ecological concern 88 
complying with the principles of green analytical chemistry [54,55].  89 
In this paper, we present a new and safe photochemically-induced fluorescence system 90 
for the determination of CBZ in environmental water samples without involving organic 91 
solvents. An acidic solution of CBZ is irradiated with two germicidal UV lamps, and the 92 
concentration of the formed photoproducts is then spectrofluorimetrically determined in the 93 
presence of pharmaceuticals (or their photoproducts) usually detected in the aquatic 94 
environment, coupling excitation-emission photoinduced fluorescence matrices (EEPIFMs) 95 
to multivariate calibration. Four chemometric algorithms which achieve the second order 96 
advantage, namely, parallel factor analysis (PARAFAC) [56] unfolded partial least-squares 97 
coupled to residual bilinearization (U-PLS/RBL) [57,58], multidimensional partial least-98 
squares [59] coupled to residual bilinearization (N-PLS/RBL), and multivariate curve 99 
resolution-alternating least-squares (MCR-ALS) [60] were applied to process the EEPIFMs. 100 
Second-order advantage refers the capacity of certain second-order algorithms to predict 101 
concentrations of sample components in the presence of any number of unsuspected 102 
constituents [61,62]. Notable differences in the prediction capabilities of the employed 103 
algorithms were observed and discussed, and the feasibility of determining CBZ in natural 104 
water samples is demonstrated. 105 
 106 
2. Experimental 107 
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 108 
2.1. Reagents and solutions 109 
 110 
CBZ was obtained from Sigma (St. Louis, MO, USA). Methanol and hydrochloric acid 111 
were purchased from Merck (Darmstadt, Germany). Compounds tested as potential 112 
interferents were of analytical grade and were used as received. The stock solution of CBZ 113 
(530 µg mL
–1
) was prepared in methanol. From this solution, more diluted aqueous working 114 
solutions were obtained. Ultrapure Milli-Q water was used throughout the work. 115 
 116 
2.2. Instrumentation 117 
  118 
 Fluorescence spectra were measured using an Aminco Bowman (Rochester, NY, USA) 119 
Series 2 luminescence spectrometer equipped with a 150 W xenon lamp. These spectra were 120 
obtained using excitation and emission wavelengths of 308 and 410 nm, respectively, and 121 
both the excitation and emission slit widths were of 8 nm using 1.00 cm quartz cells. The 122 
photomultiplier tube (PMT) sensitivity was fixed at 700 V and the temperature of the cell 123 
compartment was kept constant at 20 ºC by circulating water from a thermostatted bath 124 
(Cole-Parmer, Illinois, USA).  125 
 126 
2.3. Procedure  127 
 128 
The photodegradation reaction was carried out in a very simple reactor constructed in our 129 
laboratory, constituted by two germicidal tubes of 4 W (Fig. 2). Both the geometry of the 130 
photoreactor and the experimental conditions to reach the best signal were optimized (see 131 
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below). EEPIFMs were measured from 280 to 320 nm (each 2 nm) and from 380 to 450 nm 132 
(each 1 nm), respectively, and were then subjected to second-order data analysis. 133 
 134 
Fig. 2 Photoreactor. LD = distance between the lamps, C = quartz cells, r = reactance, t = 135 
transformer. 136 
 137 
2.4. Optimization of the parameters affecting the fluorescence signal 138 
  139 
 A five-level central composite design of 17 experiments was applied for investigating the 140 
influence of the three variables on the fluorescence intensity, with three replicates at the 141 
central point. These variables were the concentration of hydrochloric acid (CHCl), the 142 
irradiation time (IT) and the distance between the lamps (LD). The fluorescence intensity was 143 
recorded for each solution using 308 and 410 nm as excitation and emission wavelengths 144 
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respectively. The runs were carried out in a randomized sequence to minimize the effect of 145 
uncontrolled variables on the response. The resulting experimental matrix is detailed in Table 146 
1, and the quadratic regression model selected to define the relationship between the response 147 
and the variables was:  148 
     (1) 
149 
 150 
where F is the response, xi and xj are the studied factors, b0, bi, bii and bij are the intercept, 151 
linear, quadratic and interaction coefficients, and e the model error.  152 
 153 
Table 1 
Design generated for a central composite design and the obtained response values. 
Run b1–CHCl/M b2–IT/min b3–LD/cm F (response) 
1 1.50 1.00 6.00 5.8 
2 1.50 30.00 6.00 24.7 
3 2.50 7.00 8.00 16.7 
4 3.00 16.00 6.00 32.6 
5 2.50 25.00 3.50 25.4 
6 0.30 16.00 6.00 14 
7 1.50 16.00 10.00 26.5 
8 1.50 16.00 6.00 31.8 
9 0.50 7.00 8.00 15.4 
10 0.50 25.00 3.50 6.4 
11 0.50 25.00 8.00 21.8 
12 1.50 16.00 6.00 33.6 
13 2.50 25.00 8.00 29.2 
14 1.50 16.00 2.00 23.6 
15 1.50 16.00 6.00 33.7 
16 2.50 7.00 3.50 24.7 
17 0.50 7.00 3.50 6.3 
  CHCl: concentration of hydrochloric acid; IT: irradiation time; LD: distance between the 
lamps. 
 154 
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2.5. Quantitative analysis 155 
 156 
Preliminary experiments indicated that, under the established working conditions, linearity 157 
is held until 61 ng mL
–1
, which was the limiting assayed concentration in subsequent 158 
analyses. 159 
A calibration set of 9 samples was prepared, by duplicate, measuring appropriate aliquots 160 
of stock solution of CBZ into 2.00 mL calibrated flasks, evaporating the solvent with nitrogen 161 
and completing to the mark with 2 mol L
–1
 HCl. A validation set was similarly prepared 162 
employing concentrations different from those used for calibration and following a random 163 
design. With the purpose of evaluating the proposed strategy in the presence of these 164 
interferent agents, twenty additional test samples containing random concentrations of CBZ 165 
and these foreign compounds were prepared. The interferents were evaluated at the following 166 
concentration ranges: 0–5600, 0–1200, 1–9, and 0–5000 ng mL
–1 
for ibuprofen, diclofenac, 167 
piroxicam, and salicylic acid, respectively. The maximum level of each evaluated 168 
interference was selected in order to avoid the saturation of the fluorescence signal. Taking 169 
into account that the highest CBZ concentration was about 60 ng mL
–1
, with the exception of 170 
piroxicam, each interferent agent was between 16 and 90 times more concentrated than the 171 
analyte. 172 
 173 
2.6. Real water samples  174 
  175 
All investigated water samples were prepared by spiking them with CBZ at three different 176 
concentrations, obtaining levels between 0.4 and 5.5 ng mL
–1
. Tap water from Rosario city 177 
(Santa Fe, Argentina) and underground water from Funes and Venado Tuerto cities (Santa 178 
Fe, Argentina) samples were used as received. The Paraná River sample was collected near 179 
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Rosario city, and after spiking it with CBZ, it was filtered through a filter paper to remove 180 
suspended solid materials. In order to improve the sensitivity of water analysis, a solid-phase 181 
extraction (SPE) procedure with C18 membranes was applied. Prior to sample application, 182 
each membrane was conditioned with 500 µL of methanol. Positive pressure was used to 183 
force the water sample through the membrane. For concentrations of CBZ at sub-part-per-184 
billion levels, 50.0 mL of sample was employed, while a volume of 10.0 mL was used for the 185 
remaining samples. Following the extraction, the disk was dried by forcing air through it 186 
using a 25 mL syringe. Then, the retained CBZ was eluted with 500 µL of methanol and the 187 
liquid was collected in a 2.00 mL volumetric flask. After evaporation of the solvent with 188 
nitrogen, the residue was reconstituted to the mark with 2 mol L
–1
 HCl. Thus, the 189 
preconcentration factors were 25 and 5 for samples with sub-part-per-billion and part-per-190 
billion concentrations, respectively. Then, the procedure described above was performed. 191 
 192 
2.7. Software 193 
 194 
 The experimental design and optimization was carried out using Design Expert 6.0 (Stat-195 
Ease, Inc.). The employed chemometric algorithms were written in MATLAB 7.6 [63]. 196 
PARAFAC, U- and N-PLS/RBL were implemented using the graphical interface of the 197 
MVC2 toolbox, which can be freely downloaded from the webpage www.iquir-198 
conicet.gov.ar/descargas/mvc2.rar. MCR-ALS is available in the Internet at 199 
http://www.mcrals.info/. Theoretical considerations of the applied algorithms can be found in 200 
the supplementary information. 201 
 202 
3. Results and discussion 203 
 204 
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3.1. Preliminary studies 205 
  206 
 As was previously indicated, CBZ does not display native fluorescence, but emission can 207 
be obtained upon UV irradiation under certain working conditions, indicating the formation 208 
of one or more emissive photoproducts (Fig. 3A). In the literature, different CBZ 209 
photoproducts have been reported depending on the employed experimental conditions. 210 
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Fig. 3 (A) Excitation and emission fluorescence spectra of CBZ photoproducts (initial CCBZ = 212 
0, 10.1, 25.3, 48.0, and 60.0 ng mL
–1
). (B) Normalized excitation and emission fluorescence 213 
spectra of CBZ photoproducts (black line), acridine (red line) and acridone (light green line). 214 
(C) Normalized excitation and emission fluorescence spectra of CBZ (black line), ibuprofen 215 
(orange line), diclofenac (green line), piroxicam (blue line), and salicylic acid (pink line) after 216 
irradiation under the used experimental condition. 217 
 218 
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 For example, acridine and acridone were the main identified photoproducts when an acid 219 
solution of CBZ was irradiated with a 1500 W arc xenon lamp during 30 min [64]. CBZ 220 
treatment with UV irradiation (17 W mercury lamp, 254 nm) in the presence of H2O2 221 
produced acridine, a series of acridine intermediates and small amounts of salicylic acid, 222 
catechol and anthranilic acid among the reaction products [65]. Chiron et al. studied the 223 
photodegradation of CBZ in artificial estuarine water, mimicking natural processes [7]. After 224 
evaluating different experimental conditions, it was concluded that besides acridine (the 225 
major photodegradation intermediate), 10-hydroxycarbamazepine, hydroxyacridine-9-226 
carboxaldehyde, and acridone are also formed. 227 
 Under our working conditions, the obtained wide spectra with excitation and emission 228 
maxima at 308 and 410 nm respectively, do not suggest a significant contribution of either 229 
acridine or acridone (Fig. 3B). However, regardless of the nature of the formed 230 
photoproducts, a linear relationship between the CBZ concentration and the obtained 231 
fluorescence intensity was corroborated and, therefore, a quantitative analysis could be 232 
properly developed. 233 
 234 
3.2. Optimization of the experimental conditions 235 
 236 
Exploratory experiments showed that the type and concentration of acid used in the 237 
reaction medium, the time of sample irradiation and the distance between the reactor lamps 238 
(the sample is positioned equidistant between both lamps) had critical effects on the 239 
photochemically induced fluorescence. Although in some systems the presence of different 240 
organized media could sensitize photochemical reactions [66,67], in our working conditions 241 
selected surfactants (sodium dodecyl sulfate, hexadecyltrimethylammonium bromide, Triton 242 
X-100) and cyclodextrins (β-, γ-, α- and 2-hydroxy-propil-β cyclodextrins) did not produce a 243 
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significant signal improvement. On the other hand, desoxigenation of the medium with a flow 244 
of nitrogen did not improve the signal intensity. 245 
 As regards the acid employed, nitric, sulfuric and hydrochloric acids were checked. In the 246 
presence of nitric acid, signals were not detected, and the sulfuric acid background signal was 247 
significant. Hydrochloric acid produced the best signals and, therefore, it was selected for the 248 
subsequent experiments. 249 
 It was found that irradiation with two 4 W lamps, rather than using either one 4 W lamp or 250 
8 W lamps, produced an efficient photodegradation reaction of CBZ. Besides, the distance 251 
between these lamps and the time of irradiation modified the signal. These factors were 252 
optimized using a surface response methodology. Table 2 displays the ANOVA results for 253 
the selected quadratic model, where it can be appreciated that the variables explain the data 254 
and indicate that the variable effect is significant at 95 % confidence level. The coefficients 255 
estimated for the mathematical model in terms of actual factors were: –40, 31, 2.3, 6.9, –5.2,    256 
–0.08, –0.48, –1.5 for intercept, CHCl, IT, LD, (CHCl)
2
, (IT)
2
, (LD)
2
, CHCl×LD and IT×LD, 257 
respectively. 258 
  The optimum values obtained for CHCl, IT and LD were 2 mol L
–1
, 20 min and 6 cm, 259 
respectively. These conditions were used for the corresponding quantitative analysis. 260 
 It is important to point out that the geometry of the photoreactor (Fig. 2) allows the 261 
simultaneous irradiation of four solutions contained in the quartz cells. Thus, the time of 262 
irradiation is equivalent to 5 minutes per sample. 263 
 264 
3.3. Quantitative analysis 265 
 266 
 The purpose of the present work is to determine CBZ in natural matrices where other 267 
concomitantly present compounds are potentially able to produce interference through either 268 
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themselves or their fluorescent photoproducts when the sample is subjected to the irradiation 269 
protocol. Therefore, different pharmaceuticals selected from the list of organic 270 
 271 
Table 2 
Analysis of variance (ANOVA) for the selected quadratic model.
a 
Source Sum of squares DF Mean square F value p > F 
Model 1408.40 8 176.05 23.46 < 0.0001 
b1–CHCl 511.89 1 511.89 68.22 < 0.0001 
b2–IT 151.89 1 151.89 20.24 0.020 
b3–LD 58.01 1 58.01 7.73 0.0239 
b11
 
179.14 1 179.14 23.87 0.0012 
b22
 
464.96 1 464.96 61.978 <0.0001 
b33
 
88.71 1 88.71 11.82 0.0088 
b13 97.37 1 97.37 12.98 0.0070 
b23 45.05 1 45.05 6.00 0.0399 
      
Lack of Fit     0.100 
  a
 The term b12 was not significant (p > 0.05) and was excluded of the analysis. DF = degree 
of freedom; p = probability; R
2
 (coefficient of determination) = 0.959; Pred R
2
 (measures 
how well the model will predict the responses for a new experiment) = 0.794; Adeq precision 
(measures the signal to noise ratio) = 13.97. 
 272 
micropollutants usually detected in the aquatic environment were checked as potential 273 
interferents, namely ibuprofen, diclofenac, piroxicam, salicylic acid, naproxen, ketoprofen 274 
and atenolol [11,68]. We found that, after irradiation, the excitation and emission spectra of 275 
the photoproducts of the first four compounds (Fig. 1) are significantly overlapped with those 276 
corresponding to CBZ ones, producing a severe interference (Fig. 3C). Thus, for improving 277 
the selectivity of the method, a second-order calibration applying algorithms which achieve 278 
the so-called second-order advantage was proposed. 279 
  280 
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 281 
Fig. 4 Three-dimensional plots and the corresponding contour plots of excitation-emission 282 
photoinduced fluorescence matrices for (A) a validation sample containing 48.0 ng mL
–1
 283 
CBZ, (B) a test sample containing 56.0 ng mL
–1
 CBZ, 2000 ng mL
–1
 ibuprofen, 1500 ng   284 
mL
–1
 salicylic acid, 600 ng mL
–1
 diclofenac and 2 ng mL
–1
 piroxicam, and (C) a spiked river 285 
sample after solid-phase extraction (original CCBZ = 5.5 ng mL
–1
). 286 
 287 
 Firstly, EEPIFMs of CBZ photoproducts under optimal working conditions were recorded 288 
for calibration and validation samples (Fig. 4A), where only the studied analyte is present. 289 
 These matrices were successfully resolved by usual second-order algorithms such as 290 
PARAFAC, U-PLS, N-PLS and MCR-ALS (data not shown). However, the results were 291 
different when test samples containing interferent agents were processed. Fig. 4B shows the 292 
three-dimensional plot of the EEPIFM for a typical sample with interferences and the 293 
corresponding contour plot. The results obtained with different algorithms applied to these 294 
samples are discussed below. 295 
 296 
3.3.1. PARAFAC 297 
  298 
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 The PARAFAC model allowed us to obtain physically interpretable profiles. The 299 
identification of the analyte was done with the aid of the estimated excitation and emission 300 
profiles, and comparing them with those for an irradiated standard CBZ solution. The number 301 
of components was selected by the so-called core consistency analysis [69], which consists in 302 
studying the structural model based on the data and the estimated parameters of gradually 303 
augmented models. A PARAFAC model is considered to be appropriate if incorporating an 304 
additional component does not improve the fit considerably [69]. The number of components 305 
also was analysed through the spectral profiles produced by the addition of a new component. 306 
If this addition generated repeated profiles, suggesting overfitting, this new component was 307 
discarded. The number of responsive components obtained using both procedures was two in 308 
validation samples and three in samples with interferents. In validation samples, the obtained 309 
number of components could be justified taking into account the presence of two different 310 
signals corresponding to CBZ and background signals. On the other hand, in test samples 311 
interferences are extracted as a single signal. 312 
 PARAFAC was initialized with the loadings giving the best fit after a small number of 313 
trial runs, selected from the comparison of the results provided by generalized rank 314 
annihilation and several random loadings [70].  315 
 Fig. 5A shows the prediction results corresponding to the application of PARAFAC to the 316 
20 samples with interferents. As can be appreciated, the results are rather poor. This fact may 317 
be explained considering the significant spectral overlapping among the analyte and 318 
interferences, which precludes the successful decomposition of the second-order data [71]. 319 
The elliptical joint confidence region (EJCR, [72]) test for the slope and intercept of the 320 
found vs. nominal concentrations plot shows that the ideal point (1,0) lies outside the EJCR 321 
surface (Fig. 5F), also suggesting that PARAFAC is inappropriate for resolving the system 322 
under investigation. 323 
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Fig. 5 Plots for CBZ predicted concentrations in samples with interferences (test samples) as 326 
a function of the nominal values using (A) PARAFAC, (B) U-PLS/RBL, (C) N-PLS/RBL, 327 
(D) MCR-ALS (column-wise augmentation), and (E) MCR-ALS (row-wise augmentation). 328 
Solid lines indicate the perfect fits. (F) Elliptical joint regions (at 95 % confidence level) for 329 
slope and intercept of the regression of PARAFAC (red line), U-PLS/RBL (green line), and 330 
N-PLS/RBL (blue line). (G) Elliptical joint regions (at 95 % confidence level) for slope and 331 
intercept of the regression of MCR-ALS using column-wise (black line) and row-wise (pink 332 
line) augmentations. Crosses in (F) and (G) mark the theoretical (intercept = 0, slope = 1) 333 
point.   334 
 335 
3.3.2. U- and N-PLS 336 
 337 
 In the cases of U- and N-PLS/RBL, the optimum number of factors for the calibration set 338 
applying the cross-validation method described by Haaland and Thomas [73] was also two. 339 
When these algorithms were applied to samples containing interferents, in addition to the 340 
latent variables estimated from the calibration set, they required the introduction of the RBL 341 
procedure with an additional number of components corresponding to the unexpected sample 342 
constituents. This number, estimated by suitable consideration of RBL residues [74], ranged 343 
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from 1 to 2. Adding more unexpected components did not improve the fit. Apparently, 344 
PLS/RBL considers the profiles of the four interferences as additional one or two 345 
components, and is able to distinguish these combined signals from those of the analyte and 346 
the blank. Figs. 5B and 5C show the prediction results corresponding to the application of U-347 
PLS/RBL and N-PLS/RBL to the samples containing interferences. In these figures, some 348 
dispersion of the predictions with respect to the perfect fit lines is verified. While the 349 
corresponding ellipses include the theoretical (1,0) point (Fig. 5F), they show large (and 350 
undesirable) sizes. However, although these algorithms have some difficulty to solve the 351 
system under study, they are more flexible and render better results than PARAFAC. 352 
 353 
3.3.3. MCR-ALS 354 
 355 
 The MCR-ALS model decomposes an augmented data matrix, built by placing matrices 356 
for different samples adjacent to each other, in such a way that the augmentation mode is the 357 
one affected by the profile overlapping. As a result, the poor selectivity in the affected 358 
dimension is recovered in the augmented dimension. In the present system, since a significant 359 
overlapping between analyte and interferences is observed in the excitation and emission 360 
spectra, both modes of augmentation were checked. Therefore, two different data processing 361 
were performed: one of them comprised the building of augmented column-wise (emission 362 
spectral) data matrices containing the test sample data and the calibration data matrices, and 363 
the other one comprised the building of augmented row-wise (excitation spectral) data 364 
matrices, also containing the test and calibration data matrices. 365 
 Before starting resolution, the determination of the number of MCR components was 366 
estimated by applying singular value decomposition (SVD). Usually, the plot of singular 367 
values as a function of principal component number is visually inspected, locating a number 368 
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for which the plot stabilizes. This number is initially employed for MCR-ALS analysis, and is 369 
afterwards refined (increased or decreased) until an appropriate solution is found, with a 370 
reasonable least-squares fit and physically recognizable profiles. Given the number of 371 
responsive components, their spectra were then obtained from the analysis of the so-called 372 
“purest” spectra, based on the SIMPLISMA methodology, a multivariate curve resolution 373 
algorithm which extracts the purest spectra of the mixture from a series of spectra of mixtures 374 
of varying composition [75]. The spectra provided by SIMPLISMA were suitable to perform 375 
the resolution and, therefore, it was not necessary to include reference spectra for the analyte 376 
as initial estimates for MCR-ALS. In the present system, the number of MCR components in 377 
both augmentation modes was three. Apparently, the algorithm combines the signals of 378 
interferents but perfectly distinguishes them from those belonging to the analyte and, as will 379 
be shown below, yields very good predictions. 380 
 During the iterative procedure leading to chemically recognizable solutions the constraint 381 
of non-negativity in both data modes was applied. The selected MCR convergence criterion 382 
was 0.1% (relative change in fit for successive iterations) and the maximum number of 383 
iterations was set to 1000. Convergence was achieved after less than 300 iterations in most of 384 
the evaluated samples. Further, the quality of the MCR-ALS recovered spectral profiles was 385 
evaluated using the criterion of similarity which involves a comparison, through the 386 
correlation coefficient (R) between the reference and evaluated spectrum [76]. The value of R 387 
found for CBZ photoproducts in the excitation and emission spectra were 0.9992 and 0.9997, 388 
respectively, corroborating the excellent quality of the MCR-ALS obtained results. 389 
 Figs. 5D and 5E show the prediction results corresponding to the application of MCR-390 
ALS to the same test samples described above using the column and row-wise augmentation 391 
respectively. As can be observed, in both cases the predictions are in good agreement with 392 
the corresponding nominal values, with the results of column-wise augmentation being 393 
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slightly better. This fact could be ascribed to the better selectivity achieved through the 394 
excitation spectra. The EJCR test (Fig. 5G) corroborates that both ellipses have a small size 395 
and include the theoretically expected values of (1,0), demonstrating the accuracy of the used 396 
methodologies. 397 
 The statistical results are complemented with the values shown in Table 3. The relative 398 
error of prediction indicates acceptable precision, and both the limit of detection (LOD) and 399 
limit of quantification (LOQ) obtained are suitable, taking into account that a very simple 400 
methodology is applied to a complex multicomponent system.  401 
 402 
 403 
The latter two figures of merit have been estimated using the expressions recommended by 404 
IUPAC for the detection capabilities, which take into account the so-called Type 1 and 2 405 
errors (false detects and false non-detects respectively) [77]. They were applied to the 406 
pseudo-univariate calibration plot (analyte scores vs. nominal concentrations) provided by 407 
MCR-ALS, as previously suggested [78]. 408 
 409 
Table 3 
Statistical results for CBZ using the proposed methodolgy and MCR-ALS (column-wise 
augmentation). 
 Test samples
a 
 Real water samples
b 
 Real water samples
c
 
LOD
d
 (ng mL
–1
) 5  1  0.2 
LOQ
e
 (ng mL
–1
) 15  3  0.6 
RMSEP
f
 (ng mL
–1
) 4  0.4  0.1 
REP
g
 (%) 13  7  2 
a
 Twenty samples containing ibuprofen, diclofenac, piroxicam, salicylic acid as interferents.  
b
 Preconcentration factor = 5 (the results refer to the original water sample before SPE). 
c
 Preconcentration factor = 25 (the results refer to the original water sample before SPE). 
d 
LOD, limit of detection calculated according to ref. 78. 
e
 LOQ, limit of quantitation calculated as LOD×(10/3.3).  
f 
RMSEP, root-mean-square error of prediction. 
g
 REP, relative error of prediction. 
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3.4. Real water samples 410 
  411 
With the purpose of evaluating the present method in real samples and demonstrating its 412 
ability of overcoming the interference from background matrices, waters from different 413 
origins were analysed. CBZ is detected in water bodies in a wide range of concentrations, 414 
generally in the order of part- and sub-part-per-billion levels. Therefore, the sensitivity of the 415 
present method was improved using a pre-concentration step by employing C18 membrane-416 
SPE. At this point, it is necessary to point out that the selection of C18 membranes is based 417 
on our excellent experience with this solid-support as extractor of organic compounds 418 
[79−81].  Although other materials could be used for the extraction procedure, previously 419 
reported experiments performed with different commercial and in-house ion-exchange 420 
polymeric sorbents were not successful for CBZ extraction [82].  421 
 Fig. 6A shows both the excitation and emission spectra of CBZ photoproducts and the 422 
signal of a typical real water sample after the SPE procedure. As can be seen, the selected 423 
sample (river water) shows intense fluorescence signals in the same region where the CBZ 424 
photoproducts emit, which are ascribed to dissolved organic matter [83]. These overlapping 425 
would preclude the direct measurement of the analyte, but it does not represent a problem 426 
when using second-order approaches. Fig. 4C shows both three-dimensional plot of the 427 
EEPIFM and the corresponding contour plot of real sample of river spiked with CBZ and 428 
treated with C18 membrane. 429 
A recovery study was performed by spiking water samples with appropriate amounts of 430 
CBZ, in triplicate, at three different concentration levels, following the treatment indicated in 431 
the experimental section. According to the previous results, MCR-ALS was selected to 432 
resolve these samples, and the outstanding results obtained (Table 4, Fig. 6B) suggest that the 433 
method can overcome the problem of the presence of unexpected interferents from the 434 
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background of the real samples. Table 3 displays the corresponding figures of merit obtained 435 
for these samples. 436 
 In comparison with the performances of selected methods for the determination of CBZ in 437 
natural waters (Table 5), limits of detection from 0.2×10
–3
 to 10 ng mL
−1 
have been found 438 
using different strategies, all using pre-concentrations procedures and most of them applying 439 
chromatographic (separation) approaches. In the present case, a low limit of detection is 440 
achieved in real samples (LOD = 0.2 ng mL
–1
) applying a non-sophisticated method and 441 
without using organic solvents. Note a solid-phase extraction procedure using a higher 442 
amount of sample (> 50 mL) allows decrease even more the LOD. Additionally, a sampling 443 
rate of about six samples per hour (including the EEPIFM measuring) makes the method very 444 
advantageous. 445 
 446 
Table 4 
Recovery study of CBZ for spiked water samples.
a
 
Sample Taken (ng mL
-1
) Found (ng mL
-1
)
b 
Recovery (%)
 
Underground water 
(Funes City) 
0.70 
2.00 
4.00 
0.8 (0.2) 
2.3 (0.3) 
4.5 (0.9) 
114 
115 
112 
Underground water 
(Venado Tuerto City) 
0.40 
3.00 
5.00 
0.47 (0.01) 
2.8 (0.1) 
5.5 (0.2) 
117 
93 
110 
Tap water 
(Rosario City)  
0.80 
1.20 
4.50 
0.86 (0.02) 
0.93 (0.01) 
4.0 (0.2) 
107 
78 
89 
River water 
(Paraná River) 
0.00 
2.50 
5.50 
ND
c
  
2.7 (0.5) 
6.1 (0.1) 
 
108 
111 
 a
 using MCR-ALS algorithm (column-wise augmentation). 
 b
 Mean of three determinations. Standard deviations between parentheses. 
 c
 ND, not detected. 
 447 
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Fig. 6 (A) Excitation and emission fluorescence spectra of CBZ photoproducts (CCBZ = 40.0 449 
ng mL
-1
, black line) and background signals of a river sample without CBZ after the SPE 450 
treatment (sky-blue dashed line). (B) Plot for MCR-ALS predicted concentrations of CBZ as 451 
a function of the nominal values in a river (diamonds) and tap water (squares) samples, and in 452 
two different underground water samples (circles and triangles) spiked analyte (error bars 453 
correspond to triplicates). The inset shows the corresponding elliptical joint region at 95% 454 
confidence level. The cross marks the theoretical (intercept = 0, slope = 1) point. 455 
 456 
4. Conclusions 457 
 A novel and simple fluorimetric method for carbamazepine (CBZ) determination was 458 
developed and successfully applied to the quantitation of this emerging contaminant in water 459 
samples. Analyses were accomplished in a significant short time, with a minimum operator 460 
effort and avoiding the use of organic solvents. The selectivity of the method is achieved 461 
through the coupling of multivariate calibration. Among the different second-order 462 
algorithms investigated, multivariate curve resolution-alternating least-squares (MCR-ALS) 463 
showed a superior predictive capability and would be the recommended one in situations 464 
where interferences present similar profiles as the investigated compound.  465 
24 
 
Table 5 
Analytical performance of selected methods reported for the determination of CBZ in natural waters.  
Method VSa Concentration levelb RSDc and RECc Sample Ref 
SPME-GC-MS 4 LOD = 1.0
 
RSD = 12.0 GW, SW [20] 
SPE-GC-MS 1000 LOD = 6.5×10–3 (nanopure water). LOD = 
8.7×10–3 (SW); 0.035–0.060 (lake); 0.030–
0.250 (river); 0.100–0.800 (WWTP) 
REC = 46-65 
(0.100 ng mL–1) 
SW, STPEs [21] 
SPE-GC-MS 1000  LOD = 9.6×10–3; LODet = 32×10–3 REC = 80 (TW) and 
74 (SW) 
TW, SW [22] 
SPE-HPLC-PIF 250 Without SPE: LOD = 30; LOQ = 100.  
With SPE: 12 (SS with 10 ng mL–1 added) 
RSD = 3.4 
 
STP-WW [23] 
SPE-LC-MS/MS  STPI: 0.369. STPE: 0.426. SW (river): 
0.7×10–3. SS: 0.100 
REC = 83.6 -103.5; 
RSD = 5.9 
STPI, STPE, SW [24] 
SPE-GC-MS and 
SPE-LC-MS/MS 
500-
1000 
MC = 1.2 Absolute REC = 89 
(GC) and 99 (LC) 
STPEs [25] 
SPE-GC-MS 500 LOD = 2.2; LOQ = 0.074 REC = 67 Municipal STP [26] 
SPE-LC-MS/MS  STPI: 0.356; STPE: 0.251  STPI, STPE, biosolids [27] 
SPE-GC-MS (on-line 
derivatization) 
50-
500 
LOQ = 8.0×10–3 REC = 79-108 TW, SW, WWE, GW [28] 
 
SPE-HPLC-MS 500 LOQ = 1.3×10–3 (STPE); Found (STPE) = 
0.033– 1.3 
RSD = 0.7 % (10 
ng/injected); RSD = 
2.88 (100 ng 
/injected)  
Urban WWs [29] 
SPE-HPLC-DAD 500- 
1000 
WWI: LOD = 0.04; LOQ = 0.12. WWE: 
LOD = 0.02; LOQ = 0.06 
REC = 95, RSD = 
4.3 
WWI, WWE [30] 
SPE-GC-MS 500 LOQ = 0.030 REC = 110; RSD = 
11.5 
River water [31] 
SPE-LC-MS/MS 100 LOD = 7; LOQ = 19 REC = 88.1 (1 ng 
mL–1); RSD = 2.2 
Hospital WWE [32] 
 SPE-LC-MS/MS  
 
100-
1000 
STPI: LOQ = 0.02; MC = 2. STPE: LOQ = 
0.01; MC = 1.9. SW: LOQ = 0.002; MC = 
0.081 
Absolute REC  = 36-
98 
STPI, STPE, SW, GW, 
DW 
[36] 
SPE (MIP)-LC-MS 100 1 REC = 80 WW [38] 
SPE-voltammetry  LOD = 9.4; LOQ = 33. SS: 500 REC = 95.8; RSD = 
5.7 
WW [43] 
Off- and on-line SPE-
LC-QqQ-MS 
500 LOD = 0.2×10–3 
 
RSD < 15 SW and DW [15] 
SPE-LDTD-APCI-
MS/MS 
100 0.012 RSD = 8 municipal WW [45] 
SPE-EEPIF 10-50 LOD = 1 (PCF = 5); LOD = 0.2 (PCF = 25) REC = 78-117; REP 
= 2-7 
SW, UW This 
work 
 a VS, volume of sample in mL. 
 b For comparison, concentration units were unified to ng mL–1.  
 c Relative standard deviation (RSD) and recovery (REC), both in %.  
 Abbreviations: APCI, atmospheric pressure chemical ionization; DW, drinking water; EEPIF, excitation-emission 
photoinduced fluorimetry; GW, groundwater; LC, liquid chromatography; LDTD, laser diode thermal desorption; LOD, limit 
of detection, LODet, limit of determination, LOQ, limit of quantification; MC, maximum found concentration; MIP, 
molecularly imprinted polymer; MS, mass spectrometry; MS/MS, tandem mass spectrometry; PCF, preconcentration factor; 
PIF, photoinduced fluorescence; QqQ, triple quadrupole; REP, relative error of prediction; REC, recovery; RSD, relative 
standard deviation; SPE, solid-phase extraction; SPME, solid-phase microextraction; SS, spiked sample; STP, sewage 
treatment plant; STPE, sewage treatment plant effluent; STPI, sewage treatment plant influent; SW, surface water; TW, tap 
water; UW, underground water; VS, volume of sample; WW, wastewater; WWE, wastewater effluent; WWI, wastewater 
influent.  
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Glossary 
CBZ: carbamazepine. 
CCBZ: concentration of carbamazepine. 
CHCl: concentration of hydrochloric acid. 
EEPIFMs: excitation-emission photoinduced fluorescence matrices. 
EJCR: elliptical joint confidence region. 
EU: European Union. 
IT: irradiation time.  
LD: distance between the lamps. 
LOD: limit of detection. 
LOQ: limit of quantification. 
MCR-ALS: multivariate curve resolution-alternating least squares. 
N-PLS/RBL: multidimensional partial least-squares/ residual bilinearization. 
PARAFAC: parallel factor analysis. 
PMT: photomultiplier tube. 
R: correlation coefficient. 
SPE: solid-phase extraction. 
SVD: singular value decomposition. 
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U-PLS/RBL: unfolded partial least-squares/residual bilinearization. 
 
